A. Seirafi Tehranian - Gynecology

Author Information

Afsaneh Tehranian is affiliated with the Department of Obstetrics and Gynecology at Arash Women's Hospital, which is part of the Tehran University of Medical Sciences in Tehran, Iran. With a strong background in gynecological research, Dr. Tehranian has made significant contributions to the field, focusing on cervical intraepithelial neoplasia, HPV infections, ovarian cancer, and pregnancy-related complications.

Research Contributions

Dr. Afsaneh Tehranian has authored numerous papers that address critical issues in gynecology and obstetrics. Her research spans various topics including effective case finding for high-grade cervical intraepithelial neoplasia in low-resource settings, the impact of diabetes on ovarian cancer survival, and the outcomes of COVID-19 pneumonia in pregnant women. She has also explored the immunogenicity and safety of HPV vaccines, and innovative treatments for endometrial hyperplasia and ovarian diseases. Dr. Tehranian’s work is characterized by its focus on improving women's health through both clinical trials and epidemiological studies.

Aliases

A Tehranian, A. Seirafi Tehranian, A. Tehranian, Afsaneh Tehranian

Publication and Citation Metrics

Metric	Value
Number of Papers	51
Number of Citations	271
h-index	11

Publications:

Effective High Grade Cervical Intraepithelial Neoplasia Case Finding in Low Resource Settings

DOI: 10.47176/mjiri.36.33

Year: 2022

Comparison of cytopathologic findings in patients with negative Pap test and positive high-risk HPV infection among three groups

DOI: 10.1007/s00404-022-06444-0

Year: 2022

Immunogenicity and safety of a bivalent, adjuvant system 04-adjuvanted human papillomavirus vaccine in healthy female volunteers aged 15-25: a randomized, double-blind, phase III, noninferiority clinical trial.

DOI: 10.1097/CEJ.0000000000000753

Year: 2022

Characteristics and outcomes of COVID‐19 pneumonia in pregnancy compared with infected nonpregnant women

DOI: 10.1002/ijgo.13697

Year: 2021

Ovarian mature cystic teratoma with malignant transformation: two case reports

DOI: 10.1186/s13256-020-02594-4

Year: 2021

Total Uterine Inversion After Normal Vaginal Delivery: A Case Report

DOI: 10.18502/crcp.v6i3.7126

Year: 2021

The impact of adjunctive metformin to progesterone for the treatment of non-atypical endometrial hyperplasia in a randomized fashion, a placebo-controlled, double blind clinical trial

DOI: 10.1016/J.JOGOH.2020.101863

Year: 2021

An Ovarian Hydatid Disease Imitating Ovarian Neoplasm: A Case Report

DOI: 10.1089/GYN.2020.0135

Year: 2021

The impact of the additional metformin to the treatment of endometrial hyperplasia without atypia in addition to progesterone in a randomized fashion, a placebo-controlled, double blind clinical trial.

DOI: 10.1016/j.jogoh.2020.101863

Year: 2020

Impact of diabetes mellitus on epithelial ovarian cancer survival

DOI: 10.1186/s12885-018-5162-3

Year: 2018

What is Endometrial Thickening?

Are there any risks associated with fertility treatments?

What are some notable initiatives in Gynecology?

What are the Implications for Family Planning?

What Happens During an MRI Scan?

When Should It Be Done?

What is Chorionic Villus Sampling (CVS)?

How Does COPD Affect Women Differently?

What Should a Patient Do If They Feel Uncomfortable?

What are the Alternatives to PTU?

Partnered Content Networks

Relevant Topics